Targeting PLD1 alone or in combination with TMZ attenuated GBM tumorigenicity through microRNA (miR)‐320a and miR‐4496‐mediated downregulation of TMZ resistance factors, including MGMT. Here, PLD1 is linked to glioblastoma.